Bath & Body Works, Inc. (NYSE:BBWI) Shares Acquired by UMB Bank n.a.

UMB Bank n.a. increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 58.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 905 shares of the company’s stock after buying an additional 335 shares during the period. UMB Bank n.a.’s holdings in Bath & Body Works were worth $35,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. True Wealth Design LLC boosted its holdings in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after purchasing an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of Bath & Body Works during the 3rd quarter worth $39,000. TD Private Client Wealth LLC grew its stake in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. Finally, Meeder Asset Management Inc. raised its stake in Bath & Body Works by 480.3% in the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock valued at $55,000 after buying an additional 1,436 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI opened at $36.98 on Friday. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The stock has a market cap of $8.01 billion, a price-to-earnings ratio of 9.02, a price-to-earnings-growth ratio of 1.01 and a beta of 1.82. The firm has a 50 day simple moving average of $36.86 and a 200-day simple moving average of $33.64.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.48 earnings per share. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were paid a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.16%. Bath & Body Works’s payout ratio is currently 19.51%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on BBWI shares. TD Cowen boosted their target price on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $39.00 to $41.00 and gave the company a “neutral” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft boosted their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley lowered their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Finally, Telsey Advisory Group reissued an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.